Disulfiram enhances subjective effects of dextroamphetamine in humans

Pharmacology Biochemistry and Behavior

Volumn 90, Issue 3, 2008, Pages 394-398

  Sofuoglu, Mehmet ^a   Poling, James ^a   Waters, Andrew ^a   Sewell, Andrew ^a   Hill, Kevin ^a,b   Kosten, Thomas ^a,c  

^a YALE UNIVERSITY   (United States)

^b MCLEAN HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Amphetamine; Dextroamphetamine; Disulfiram; Psychostimulants

Indexed keywords

DEXAMPHETAMINE; DISULFIRAM; PLACEBO;

ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; COGNITION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENTIATION; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SINGLE DRUG DOSE;

ADULT; AFFECT; ALCOHOL DETERRENTS; AMPHETAMINE-RELATED DISORDERS; BLOOD PRESSURE; COGNITION; CROSS-OVER STUDIES; DEXTROAMPHETAMINE; DISULFIRAM; DOPAMINE UPTAKE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; HYDROCORTISONE; MALE; PROLACTIN; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES; REACTION TIME;

EID: 44649156315     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.03.021     Document Type: Article

References (35)

1. Baker J.R., Jatlow P., and McCance-Katz E.F. Disulfiram effects on responses to intravenous cocaine administration. Drug Alcohol Depend 87 (2007) 202-209
2. Brauer L.H., and de Wit H. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers. Biol Psychiatry 39 (1996) 26-32
3. Carroll K., Ziedonis D., O'Malley S., McCance-Katz E., Gordon L., and Rounsaville B. Pharmacologic interventions for alcohol- and cocaine-abusing individuals: a pilot study of disulfiram vs. naltrexone. Am J Addict 2 (1993) 77-79
4. Carroll K.M., Nich C., Ball S.A., McCance E., and Rounsavile B.J. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction 93 (1998) 713-727
5. Carroll K.M., Fenton L.R., Ball S.A., Nich C., Frankforter T.L., Shi J., et al. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch Gen Psychiatry 61 (2004) 264-272
6. Charmandari E., Tsigos C., and Chrousos G. Endocrinology of the stress response. Annu Rev Physiol 67 (2005) 259-284
7. Cubells J.F., and Zabetian C.P. Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology. Psychopharmacology (Berl) 174 (2004) 463-476
8. Faiman M.D., Jensen J.C., and Lacoursiere R.B. Elimination kinetics of disulfiram in alcoholics after single and repeated doses. Clin Pharmacol Ther 36 (1984) 520-526
9. Farrin L., Hull L., Unwin C., Wykes T., and David A. Effects of depressed mood on objective and subjective measures of attention. J Neuropsychiatry Clin Neurosci 15 (2003) 98-104
10. Fillmore M.T., Rush C.R., and Marczinski C.A. Effects of d-amphetamine on behavioral control in stimulant abusers: the role of prepotent response tendencies. Drug Alcohol Depend 71 (2003) 143-152
11. Fischman M.W., Schuster C.R., Resnekov L., Shick J.F., Krasnegor N.A., Fennell W., et al. Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch Gen Psychiatry 33 (1976) 983-989
12. Freeman M.E., Kanyicska B., Lerant A., and Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev 80 (2000) 1523-1631
13. George T.P., Chawarski M.C., Pakes J., Carroll K.M., Kosten T.R., and Schottenfeld R.S. Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. Biol Psychiatry 47 (2000) 1080-1086
14. Grady T.A., Broocks A., Canter S.K., Pigott T.A., Dubbert B., Hill J.L., et al. Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers. Psychiatry Res 64 (1996) 1-10
15. Hameedi F.A., Rosen M.I., McCance-Katz E.F., McMahon T.J., Price L.H., Jatlow P.I., et al. Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans. Biol Psychiatry 37 (1995) 560-563
16. Han D.D., and Gu H.H. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6 (2006) 6
17. Hill K.P., and Sofuoglu M. Biological treatments for amfetamine dependence: recent progress. CNS Drugs 21 (2007) 851-869
18. Hughes J.C., and Cook C.C. The efficacy of disulfiram: a review of outcome studies. Addiction 92 (1997) 381-395
19. Karamanakos P.N., Pappas P., Stephanou P., and Marselos M. Differentiation of disulfiram effects on central catecholamines and hepatic ethanol metabolism. Pharmacol Toxicol 88 (2001) 106-110
20. Lott D.C., Kim S.J., Cook E.H., and de Wit H. Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology 30 (2005) 602-609
21. Manly T., Davison B., Heutink J., Galloway M., and Robertson I.H. Not enough time or not enough attention? Speed, error and self-maintained control in the Sustained Attention to Response Test (SART). Clin Neuropsychol Assess 3 (2000) 167-177
22. Martin W.R., Sloan J.W., Sapira J.D., and Jasinski D.R. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12 (1971) 245-258
23. Manly T., Lewis G.H., Robertson I.H., Watson P.C., and Datta A.K. Coffee in the cornflakes: time-of-day as a modulator of executive response control. Neuropsychologia 40 (2002) 1-6
24. McCance-Katz E.F., Kosten T.R., and Jatlow P. Disulfiram effects on acute cocaine administration. Drug Alcohol Depend 52 (1998) 27-39
25. McNair D., Lorr M., and Dropperman L. Manual for profile of mood states (1971), Educational and industrial testing services, San Diego, CA
26. Petrakis I.L., Carroll K.M., Nich C., Gordon L.T., McCance-Katz E.F., Frankforter T., et al. Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction 95 (2000) 219-228
27. Physicians' Desk Reference. Montvale, N.J.: PDR. Medical Economics Data; 2008.
28. Robertson I.H., Manly T., Andrade J., Baddeley B.T., and Yiend J. 'Oops!': performance correlates of everyday attentional failures in traumatic brain injured and normal subjects. Neuropsychologia 35 (1997) 747-758
29. SAMHSA. Substance Abuse and Mental Health Services Administration. Results from the 2003 National Survey on Drug Use and Health: national findings (2004)
30. Seiden L.S., Sabol K.E., and Ricaurte G.A. Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 33 (1993) 639-677
31. Shallice T., Marzocchi G.M., Coser S., Del Savio M., Meuter R.F., and Rumiati R.I. Executive function profile of children with attention deficit hyperactivity disorder. Dev Neuropsychol 21 (2002) 43-71
32. Sofuoglu M., and Kosten T.R. Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opin Emerg Drugs 11 (2006) 91-98
33. Sofuoglu M., Waters A.J., Mooney M., and Kosten T. Riluzole and d-amphetamine interactions in humans. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 16-22
34. Tidey J.W., O'Neill S.C., and Higgins S.T. d-amphetamine increases choice of cigarette smoking over monetary reinforcement. Psychopharmacology (Berl) 153 (2000) 85-92
35. Vaccari A., Saba P.L., Ruiu S., Collu M., and Devoto P. Disulfiram and diethyldithiocarbamate intoxication affects the storage and release of striatal dopamine. Toxicol Appl Pharmacol 139 (1996) 102-108